Navigation Links
LCA-Vision Reports 2011 Second Quarter Procedure Volume
Date:7/6/2011

CINCINNATI, July 6, 2011 /PRNewswire/ -- LCA-Vision Inc. (NASDAQ: LCAV), a leading provider of laser vision correction services under the LasikPlus® brand, today reported that 14,081 procedures were performed during the second quarter of 2011, compared with 15,266 procedures (62 vision centers) during the second quarter of 2010.  Same-store procedures (53 vision centers) increased slightly year-over-year from 13,943 procedures during the second quarter of 2010, the third consecutive quarter of year-over-year same-store procedure growth.

LCA-Vision will release second quarter 2011 financial results prior to market opening on Tuesday, July 26, 2011.  A conference call and webcast to discuss the results also will be held on Tuesday, July 26, 2011 at 10:00 a.m. Eastern Time.

To access the conference call, dial 866-322-1352 (within the United States and Canada), or 706-643-6246 (international callers).  The webcast will be available at the investor relations section of LCA-Vision's website.  A replay of the call and webcast will begin approximately two hours after the live call has ended.  To access the replay, dial 800-642-1687 (within the United States and Canada), or 706-645-9291 (international callers) and enter the conference ID number: 78217237.

About LCA-Vision Inc./LasikPlus®LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, operates 53 LasikPlus® fixed-site laser vision correction centers in 26 states and 41 markets in the United States.  Additional company information is available at www.lca-vision.com and www.lasikplus.com. Earning Trust Every Moment;Building Relationships for a Lifetime.For Additional InformationCompany Contact:Investor Relations Contact:Barb Kise

Jody CainLCA-Vision Inc.

Lippert/Heilshorn & Associates513-792-9292

310-691-7100
'/>"/>

SOURCE LCA-Vision Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ChemoCentryx Reports Novel CCR2 Antagonist Significantly Improves Kidney Function and Hyperglycemia in Models of Type 2 Diabetes
2. ReportsnReports - Multitargeted Therapies: Promiscuous Drugs and Combination Therapies
3. BioDrain Medical, Inc. Reports Results of Annual Meeting
4. Cell Therapeutics, Inc. Reports Outcome of Special Meeting of Shareholders
5. Enzymatics Reports Latest Growth Figures; Confirms Massachusetts Emerging Role as Leading Bio-manufacturing Center
6. Cantel Medical Reports 18% Increase in Net Income on 24% Increase in Sales
7. Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765
8. Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
9. Cyberonics Reports Record Fiscal 2011 Results and Provides Fiscal 2012 Guidance
10. China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results
11. Encision Reports Profitable Fourth Quarter and Fiscal Year 2011 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/6/2017)... N.Y. , Sept. 6, 2017   PDI , ... announced it will host an educational session focused on ... bloodstream infection (CLABSI) prevention at the 2017 Annual Scientific ... which will take place at the Phoenix ... from Sept. 16-19, will also feature PDI,s ...
(Date:9/5/2017)... N.J. , Sept. 5, 2017  Getinge, ... has created a vibrant charitable donation program -- ... and support congenital heart defect research by The ... providers and the general public are encouraged to ... and submit the completed artwork to the gallery ...
(Date:9/1/2017)... 1, 2017  Bayer will present the latest research from ... Medical Oncology (ESMO) 2017 Congress, September 8-12 in ... preclinical and clinical data on Bayer,s marketed portfolio and late-stage ... "We value the ... cancer research at ESMO," said Carsten Brunn , Head ...
Breaking Medicine Technology:
(Date:9/20/2017)... Texas (PRWEB) , ... September 20, 2017 , ... ... in the Orthodontics and Clear Aligner clinical and commercial support services market) has ... of Dentistry (PGSD) in Sydney, Australia. , The PGSD is the first ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... In just ... Brain Booster has already been receiving positive feedback from customers trying the product for ... , Daily Brain Booster was developed by neurosurgeon Shawn Moore, MD, for everyone ...
(Date:9/20/2017)... , ... September 20, 2017 , ... ... of older Americans at risk of price gouging for their prescription drugs, according ... (TSCL) . “Because Medicare isn’t negotiating on our behalf, there’s no consistency in ...
(Date:9/20/2017)... ... , ... “RECYCLED Ezekiel's Plan for Freedom from ADDICTION”: A ... is the creation of published author, Bill Miller. Bill Miller has a ... more than a decade of addiction to prescription drugs. He has a ...
(Date:9/20/2017)... , ... September 20, 2017 , ... “Psalms of Humidity”: ... peace of mind and move the readers one step closer to God. “Psalms of ... realized that his mistakes that have been made within his life are the very ...
Breaking Medicine News(10 mins):